just on the US market numbers, there are currently around 32 million people with diabetes. If we assume a standard royalty rate of 7.5% (industry standards range from 5-15%) and a 10% take up of the test per annum and a US$150 cost of the test, that equates to around AUD$52 million in royalties per annum.
if you assume a 15% penetration rate, that equates to around AUD$78 million per annum. PIQ is undervalued on so many metrics in my opinion.
DYOR
Ann: Trading Halt, page-9
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.040(3.92%) |
Mkt cap ! $133.6M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.03 | $10.13K | 9.586K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5590 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 7500 | 1 |
View Market Depth
| Last trade - 10.23am 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |